Simrat Randhawa Magenta Therapeutics, Inc. (MGTA) insider trading activity

MGTA Quotes by TradingView

Simrat Randhawa is EVP, Head of R&D of Magenta Therapeutics, Inc.. Currently has a direct ownership of 4,000 shares of MGTA, which is worth approximately $0. The most recent transaction as insider was on Nov 14, 2025, when has been sold 109,031 shares (Common Stock) at a price of $38.14 per share, resulting in proceeds of $4,158,442. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4K
0% 3M change
0% 12M change
Total Value Held $0

Simrat Randhawa Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 14 2025
SELL
Open market or private sale
$4,158,442 $38.14 p/Share
109,031 Reduced 96.46%
4,000 Common Stock
Nov 14 2025
BUY
Exercise of conversion of derivative security
$2,242,767 $20.57 p/Share
109,031 Added 49.1%
113,031 Common Stock
Nov 13 2025
SELL
Open market or private sale
$3,224,632 $36.85 p/Share
87,507 Reduced 95.63%
4,000 Common Stock
Nov 13 2025
BUY
Exercise of conversion of derivative security
$1,151,592 $13.16 p/Share
87,507 Added 48.88%
91,507 Common Stock
Sep 22 2023
BUY
Open market or private purchase
$26,400 $13.2 p/Share
2,000 Added 33.33%
4,000 Common Stock
Sep 21 2023
BUY
Open market or private purchase
$26,400 $13.2 p/Share
2,000 Added 50.0%
2,000 Common Stock
SR

Simrat Randhawa

EVP, Head of R&D
New York, NY

Track Institutional and Insider Activities on MGTA

Follow Magenta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MGTA shares.

Notify only if

Insider Trading

Get notified when an Magenta Therapeutics, Inc. insider buys or sells MGTA shares.

Notify only if

News

Receive news related to Magenta Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MGTA